The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A randomized phase II trial of epigenetic therapy following adjuvant treatment in patients with resected pancreatic cancer and high risk for recurrence.
 
Kim Anna Reiss
Employment - Champions Oncology (I)
Stock and Other Ownership Interests - Champions Oncology (I)
Research Funding - Champions Oncology (I)
 
Nita Ahuja
Consulting or Advisory Role - Celgene
 
Stephen Baylin
No Relationships to Disclose
 
Lauren Ann Mauro
No Relationships to Disclose
 
Sheila Linden
No Relationships to Disclose
 
Sharon White
No Relationships to Disclose
 
Daniel A. Laheru
No Relationships to Disclose
 
Joseph M. Herman
Employment - Merrimack
Stock and Other Ownership Interests - Merrimack
Honoraria - Celgene
Patents, Royalties, Other Intellectual Property - Elekta corporation
 
Christopher Lee Wolfgang
No Relationships to Disclose
 
Matthew J. Weiss
No Relationships to Disclose
 
John L. Cameron
No Relationships to Disclose
 
Martin Makary
No Relationships to Disclose
 
Nilofer Saba Azad
Honoraria - Merck
Research Funding - Astex Pharmaceuticals; Celgene; Genentech; GlaxoSmithKline; Kinex; Precision Therapeutics
Travel, Accommodations, Expenses - Merck